A doctor who accused Amgen of illegally marketing drugs lost his bid for a court hearing to challenge the company's $612 million civil settlement of misbranding claims.
Doc loses bid to challenge Amgen settlement
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.